Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Nutra Pharma Corp
NPHC
Healthcare
Biotechnology
Nutra Pharma Corp. is a holding company, which owns intellectual property and operates in the biotechnology industry. The Company conducts drug discovery research and development activities on its own and through its subsidiary, ReceptoPharm, Inc. Its first consumer product, Cobroxin, is an over-the-counter pain reliever designed to treat moderate to severe chronic pain. Its second consumer...
product, Nyloxin, is an over-the-counter pain reliever that is a stronger version of Cobroxin and is designed to treat severe chronic pain. Pet Pain-Away is an over-the-counter pain reliever designed to treat pain in cats and dogs. Equine Pain-Away is an over-the-counter topical pain reliever designed to treat pain and inflammation in horses. Its Luxury Feet is an over-the-counter pain reliever designed specifically to treat foot pain and inflammation, especially for women who wear high heels and stilettos. The Company also manufactures Cell Defender, ZMUNITY, and Avini Plus Energy, among others.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:NPHC)
New Post
View:
Posts & Comments
Threaded Posts
(29)
•••
AveragePenny
X
View Profile
View Bullboard History
Post by
AveragePenny
on Jul 26, 2021 1:35pm
Nutra Pharma Provides Business and Compliance Updates
https://www.nutrapharma.com/single-post/compliance-updates “As we originally announced in late 2020, as a consequence of a variety of issues as well as the fallout from the COVID-19 crisis; Nutra
...more
(29)
•••
AveragePenny
X
View Profile
View Bullboard History
Post by
AveragePenny
on Jul 23, 2021 1:10pm
NPHC Updated Provisional Patent
Nutra Pharma has filed an updated provisional patent for the protection of their intellectual property surrounding the use of RPI-78M and analogs of the drug as potential counter-measures against
...more
(29)
•••
AveragePenny
X
View Profile
View Bullboard History
Post by
AveragePenny
on Jun 08, 2021 2:57pm
$NPHC Added Nyloxin to Their Product Offerings
https://www.newsfilecorp.com/release/86874 "We are pleased to be working with Diverse Health Services and Dr. Tent to expand the marketing of Nyloxin," explained Rik J Deitsch, Chairman and
...more
(2)
•••
2019champs
X
View Profile
View Bullboard History
Post by
2019champs
on Nov 23, 2020 7:45am
Good time to get in
Looks promisibg
(0)
•••
Smash027
X
View Profile
View Bullboard History
Post by
Smash027
on Jan 22, 2020 3:52pm
Up?
Why and what’s driving it?
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
New results add billions to Theralase's addressable market
A Junior Copper-Gold Stock Trading at a Bargain of Monumental Proportions
Flow Rate and Helium Concentration Confirms Topaz Project as World-Class Helium Well